Clearline Capital LP - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 62 filers reported holding AMRYT PHARMA PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Clearline Capital LP ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$9,187,937
+99.2%
630,174
-0.3%
1.38%
+67.9%
Q4 2022$4,613,176
+5.5%
631,9420.0%0.82%
+57.7%
Q3 2022$4,373,000
-1.0%
631,9420.0%0.52%
-8.4%
Q2 2022$4,417,000
-15.5%
631,9420.0%0.57%
-5.0%
Q1 2022$5,226,000
-19.4%
631,942
+5.3%
0.60%
-15.7%
Q4 2021$6,482,000
+6.5%
600,196
+18.7%
0.71%
+24.2%
Q3 2021$6,089,000505,4960.57%
Other shareholders
AMRYT PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders